Please make sure that the responses have the writers name so I know who to post to
Karissa Rodriguez
Jul 10, 2023 at 1:11 AM
Screening instruments are used frequently within various areas of healthcare. These tools assess or measure a specific issue for diagnostic or treatment purposes. Screening tools are used for patients to deliver treatment, reduce symptoms, and improve health outcomes, at a reasonable cost (Iragorri & Spackman, 2018). There are many factors to consider when implementing a screening instrument, such as whether it applies to a particular population and what the tool measures or assesses. Validity, reliability, specificity, and sensitivity are essential to finding and implementing an effective screening instrument.
Screening tools are commonly used in multiple areas of healthcare. Mental healthcare uses various screening tools to identify a disease process’s severity; for example, depression or alcohol withdrawal. The Patient Health Questionaire (PHQ-9) is an example of an assessment tool used to identify the presence and severity of depression based on a scoring system. “PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively” (Kroenke et al., 2018, para 3). It would be presumed that patients would score higher due to the prevalence and severity of depressive symptoms. On the contrary, patients with less symptomology would be predicted to score lower, indicating that depression is mild or not present.
Length time in terms of screening is beneficial for identifying and then treating diseases during early phases to halt the progression and improve outcomes. An overestimation of screening benefits can occur due to lead time, length, and screening biases; however, screening more frequently and preventing disease advancement is better than screening too late. Lead-time bias is an inaccuracy within the diagnostic process because the earlier the disease is identified, the longer the patient appears to have to live when the disease span is typically the same despite being found earlier (International Society for Evidence-based Healthcare, 2019). In some cases, this can determine the length of time for survival which may not be accurately portrayed. Some may wonder if an estimated timeline may impact the mental state regarding the fight to survive terminal or possibly fatal diseases.
References
Iragorri, N. & Spackman, E. (2018). Assessing the value of screening tools: Reviewing the challenges and opportunities of cost-effectiveness analysis. Public Health Rev. 2018 Jul 13;39:17. doi: 10.1186/s40985-018-0093-8. PMID: 30009081; PMCID: PMC6043991.
Kroenke, K., Spitzer, R.L., & Williams, J.B. (2018). The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. PMID: 11556941; PMCID: PMC1495268.
International Society for Evidence-based Healthcare. (2019). What are lead-time bias and length-time bias? Teachers of EBHC. https://teachingebhc.org/learning-resource/lead-time-and-length-time-bias-and-examples-to-help-clarify-the-concepts-what-are-lead-time-bias-and-length-time-bias/#:~:text=Lead-time%20bias%3A%20The%20earlier%20we%20diagnose%20a%20disease%2C,are%20more%20likely%20to%20be%20detected%20through%20screening
Reply
Martha Wydra
Jul 10, 2023 at 4:19 AM
Dr. T and Class,
Characteristics of a Good Screening Test and Factors for Implementation in a Health Clinic
Screening tests play a crucial role in early disease detection and prevention. They are employed in various healthcare settings, including health clinics, to identify individuals who may be at risk for a particular condition. To ensure the effectiveness of screening programs, it is important to consider the characteristics of a good screening test, factors for implementation in a health clinic, the impact of disease prevalence on predictive value, and the role of lead-time and length biases. This paper aims to explore these topics and provide a comprehensive understanding of screening test attributes.
Characteristics of a Good Screening Test
A good screening test possesses several key characteristics. First, it should be reliable and produce consistent results when repeated under similar conditions. Second, it should be valid, accurately identifying individuals with the disease or condition of interest. Third, the test should be sensitive enough to detect early or preclinical stages of the disease. Fourth, it should be specific to minimize false positives and avoid unnecessary follow-up procedures. Lastly, a good screening test should be feasible, affordable, and non-invasive, allowing for widespread implementation and acceptability among the target population (CDC, 2019).
Factors for Implementing a Screening Instrument in a Health Clinic
Implementing a screening instrument in a health clinic requires careful consideration of various factors. First and foremost, the clinic must have well-trained staff who can administer the test correctly and interpret the results accurately. Additionally, the availability of necessary equipment and resources is crucial. The clinic should also consider the target population’s characteristics, such as age, gender, and ethnicity, to ensure the screening program is tailored to their needs. Moreover, logistical considerations, such as appointment scheduling and result reporting mechanisms, must be in place to ensure an efficient workflow (Moyer, 2019).
Predictive Value and Disease Prevalence
The predictive value of a screening test is influenced by the prevalence of the disease in the population being screened. Prevalence refers to the proportion of individuals with the disease in a given population. When the prevalence of a disease is low, even a highly specific screening test may produce a high number of false positives, reducing the positive predictive value. Conversely, in populations with a high disease prevalence, the positive predictive value increases, as the likelihood of a positive result being a true positive is higher (Fletcher, 2020). It is essential to consider disease prevalence when interpreting screening test results and making clinical decisions.
Lead-Time and Length Biases
Lead-time bias refers to the phenomenon where early detection through screening may appear to improve survival rates, but it does not actually prolong the life expectancy of affected individuals. The apparent survival improvement arises because the time of diagnosis is earlier, thereby artificially lengthening the survival period without providing a true benefit (Feinstein, 2020). Length bias, on the other hand, occurs when a screening test predominantly detects slower-progressing or indolent forms of the disease, leading to overestimation of the efficacy of the test and potential overdiagnosis (Vickers & Sjoberg, 2021).
In summary, a good screening test should possess characteristics such as reliability, validity, sensitivity, specificity, and feasibility. Implementing a screening instrument in a health clinic requires considering factors like trained staff, resources, target population characteristics, and logistics. The predictive value of a screening test varies with disease prevalence, with higher prevalence leading to higher positive predictive value. Lead-time and length biases should be carefully considered to avoid misleading interpretations of screening test outcomes. By understanding these concepts and applying them in practice, healthcare professionals can ensure the successful implementation and effective use of screening tests in health clinics.
References
Centers for Disease Control and Prevention. (2019). Principles of Epidemiology in Public Health Practice (3rd ed.). Retrieved from https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section1.html
Feinstein, A. R. (2020). Clinical Epidemiology: The Architecture of Clinical Research (4th ed.). Wolters Kluwer.
Fletcher, R. H. (2020). Epidemiology: What the Non-Epidemiologist Needs to Know. Lippincott Williams & Wilkins.
Moyer, V. A. (2019). Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 161(1), 46-60.
Vickers, A. J., & Sjoberg, D. D. (2021). Screening for Prostate Cancer. JAMA, 325(10), 998-999.
Reply
Raymonda Johnson
Jul 10, 2023 at 3:01 PM
Screening exams are essential when working through and differentiating possible diagnoses. As we all are aware, multiple diagnoses share similar, if not the same, symptoms. What makes a screening exam ‘good’ is its ability to detect disease at a stage when treatment is more effective compared to treatment after an individual develops signs and symptoms, and identification of risk factors that increase the possibilities of disease development and using this knowledge to prevent or lessen the disease by modifying the risk factors (Herman, 2006). Basic factors that should be paid close attention to are things such as an individual’s gender, age, family history, and physical symptoms, if any. Digging deeper during a screening exam consists of observational techniques, subjective symptoms reporting, and gathering pertinent background information. In the diagnostic world of HIV, there is really no screening exam available other than the standard blood, urine, or saliva testing. In a recent study conducted by Moucheraud et al., 2022 it was concluded that the screening exams utilized for HIV testing in outpatient departments do not offer clear advantages over the standard of care. The standard of care for HIV requires that infected individuals are monitored and trended at all times (Shaw et al., 2019), this will be hard when there is no real screening tool past the traditional lab testing. It can take weeks before HIV symptoms are seen in infected persons. In this present day, millions of individuals still have no idea what HIV truly is and what dangers come with the infection. This knowledge deficit clearly relates to the number of infected persons on a daily basis. It should be standard to screen sexually active persons and persons with known substance addictions for HIV and other STIs unless they decline the care. Even then proper educational and resource materials should be provided to help lessen the blow of HIV.
References
Herman MD, C. (2006). What makes a screening exam “Good”? Journal of Ethics | American Medical Association. https://journalofethics.ama-assn.org/article/what-makes-screening-exam-good/2006-01
Moucheraud, C., Hoffman, R. M., Balakasi, K., Wong, V., Sanena, M., Gupta, S., & Dovel, K. (2022). Screening adults for HIV testing in the outpatient department: An assessment of tool performance in Malawi. AIDS & Behavior, 26(2), 478–486. https://doi-org.ezproxylocal.library.nova.edu/10.1007/s10461-021-03404-8
Shaw, S., Modi, R., Mugavero, M., Golin, C., Quinlivan, E. B., Smith, L. R., Roytburd, K., Crane, H., Keruly, J., Zinski, A., & Amico, K. R. (2019). HIV standard of care for ART adherence and retention in care among HIV medical care providers across four CNICS clinics in the US. AIDS & Behavior, 23(4), 947–956. https://doi-org.ezproxylocal.library.nova.edu/10.1007/s10461-018-2320-1
The post 3 responses appeared first on My Perfect Tutors.